Successful completion of a first in human clinical study in Vienna, Austria.
Founders
Dr. John Scandurra, Dr. Karl Vollmers
Company Description
Aria CV, founded in 2010 by Drs. John Scandurra and Karl Vollmers, is focused on developing long-term implants for patients with pulmonary arterial hypertension (PAH). The company has successfully completed a first in human clinical study in Vienna, Austria and is preparing for a U.S. clinical trial under the FDA's Early Feasibility Study Program.
Market
Pulmonary Arterial Hypertension (PAH) patients
Location
St Paul,
Minnesota,
United States
Coinvestors
BioStar Ventures, Catalyst Health Ventures, Cedar Point Capital, Frontcourt Ventures, Longview Ventures, Xeraya Capital